Clinical Trial Update: Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy, androgen suppression, and docetaxel in high-risk prostate cancer after radical prostatectomy. Completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Radiation therapy
• androgen suppression therapy

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06